Patient Opportunity Equity Strategy’s Q1 2026 Investor Letter

Patient Capital Management, based in Baltimore, released its first-quarter 2026 investor letter for the “Patient Opportunity Equity Strategy”. The strategy’s long-term value approach aims to build wealth over time. It returned -5.96% net of fees in Q1, compared to the S&P 500’s -4.33% return. As per three-factor performance attribution model the underperformance was due to selection and interaction effects, partly offset by allocation effects. The year started strongly with markets reaching an all-time high in late January, then reversed. AI fears sparked a “SaaS pocalypse,” while ‘hyperscalers’ CAPEX worries affected returns. Software debt and illiquid markets unsettled private credit, leading most BDCs to restrict redemptions. Middle East conflicts pushed crude oil prices higher, further increasing the risk of inflation. Please review the Strategy’s top five holdings to gain insights into their key selections for 2026.

A copy of Patient Opportunity Equity Strategy’s Q1 2026 investor letter can be downloaded here.